
Fig 1. Molecular model of PTP signaling pathways in heterologous synapse formation. A) PTP? triggers excitatory heterologous synapse formation through a combination of extracellular and intracellular signaling components. The PTP D2 domain binds intracellular adaptor proteins (e.g., liprin-?) and substrates (e.g., p250RhoGAP and N-cadherin) to recruit the vesicular machinery for excitatory synapse development. This signal transduction model differs from that of neurexin. B) Neurexins serve as anchor proteins that transduce postsynaptic signals from various ligands (e.g., neuroligins and leucine-rich repeat transmembrane proteins) and transfer them to adjacent, but as yet unidentified, coreceptor protein(s) to mediate the signal transduction cascades necessary for full heterologous synapse formation activity.
CREDIT
Daegu Gyeongbuk Institute of Science and Technology (DGIST)
A research team led by Professor Jaewon Ko and Ji Won Um from Department of Brain and Cognitive Sciences identified a new principle of formation of brain synapses through synaptic binding protein complexes.
Many nerve cells that make up the brain control the function of the brain through synapses*. Although recent studies show that synaptic binding proteins play a certain role in the formation of synapses, detailed factors or processes for collectively controlling the synapses remain unknown.
The research team has been focusing on discovering related binding proteins and finding detailed mechanisms to identify the principles of formation of excitatory synapses among synapses.
In this study, the research team found that the interaction between the PTP? proteins and certain bone proteins among binding proteins plays a critical role in synapse formation. In particular, they have identified that the ‘normal tyrosine signaling mechanism’ resulting from the reaction of certain elements of the PTP? proteins is an essential component of synapse formation.
Given the potential correlation between proteins and mental disorders such as autism, schizophrenia, and depression that recent large-scale human genetics studies have shown, the research team’s experiment is expected to provide important clues to help analyze the causes of brain disorders and enable treatment through further studies of related proteins.
Professor Ko expressed his determination by saying, “As our recent study has reported, PTP? proteins, along with neurexin, are considered key proteins responsible for the development of neural circuits. Our world-leading research team will conduct further studies to continue research on the development of synapses and neural circuits.”
Learn more: One step closer to finding a cure for brain diseases
The Latest on: Brain disease
[google_news title=”” keyword=”brain disease” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Brain disease
- Is depression lifting? AI that interprets brain waves has answerson September 22, 2023 at 1:01 pm
After 24 weeks of stimulation, nine of the ten participants showed a substantial improvement in their symptoms, and seven met the criteria for disease remission. Mayberg and her colleagues used an AI ...
- Brain’s Blue Spot, Locus Coeruleus, Is A Key Player in Sleep Quality and Memoryon September 22, 2023 at 11:52 am
Researchers have shed light on the vital role of the locus coeruleus in regulating REM sleep and its effects on cognitive processes.
- NYC man’s fatal brain disease linked to COVID-19: ‘Highly likely’on September 22, 2023 at 10:56 am
deadly brain diseases. Doctors from the Department of Internal Medicine at Mt. Sinai Queens said it’s “highly likely” COVID contributed to a New York City man’s fatal prion disease. Two months before ...
- Researchers connect Alzheimer's-associated genetic variants with brain cell functionon September 22, 2023 at 7:56 am
Scientists studying Alzheimer's disease (AD) have identified thousands of genetic variants in the genome in the development of this progressive neurodegenerative disease.
- Researchers find success with stem cell therapy in mice model of Alzheimer's diseaseon September 22, 2023 at 6:56 am
Stanford Medicine researchers are hopeful that a proof-of-concept treatment in mice—blood stem cell transplants—may reduce signs of Alzheimer's disease.
- Traumatic brain injury linked to heart problemson September 22, 2023 at 6:55 am
While the neurological impact of a traumatic brain injury (TBI) has long been studied, new research suggests TBIs are also hard on the heart.
- Alarming new side effect of Covid detected in man who died from devastating ‘brain eating disease’on September 22, 2023 at 4:25 am
JUST when you thought we were through the discovery stage of the pandemic, scientists have discovered another rare side effect of Covid. It comes as a man died after developed a rare brain disease ...
- Alzheimer's disease: Mystery of dying brain cells solvedon September 22, 2023 at 2:01 am
About 55 million people live with dementia worldwide. New research into why brain cells die is enabling scientists to develop effective Alzheimer's drugs.
- Alzheimer's Disease Symptoms: 8 Early SIGNS of This Severe Illness Affecting The Brainon September 21, 2023 at 10:01 pm
Alzheimer's is a brain disease that causes a slow decline in memory, thinking and reasoning skills. Here are 8 warning signs and symptoms that you must know.
via Bing News